Intrinsic Value
Sage Therapeutics, Inc. (SAGE)
$13.94
+0.83 (+6.37%)
Enterprise Value | -7,153,619,137,376.09 |
---|---|
Net Debt | -65.83 |
Equity Value | -7,153,619,137,310.27 |
Shares Outstanding | 59.84 |
Equity Value Per Share | -119,552,884,793.24 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt